How weight loss drugs could impact stocks
- Update Date:
- Post Date:
Weight loss drugs, such as Novo Nordisk’s (NVO) Ozempic and Wegovy, continue to grow in popularity. With many brand and retailer CEOs signaling the hit to snack food sales, how will these drugs impact the packaged food industry? Morgan Stanley Equity Research Analyst Pam Kaufman joins Yahoo Finance Live to discuss. “We see long-term implications across the food ecosystem from the growing adoption of GLP-1 anti-obesity drugs,” Kaufman says, citing implications for packaged foods, restaurants, beverages, and food retail. “Our biopharma analysts expect drug use to grow fivefold over the next 12 years and project that about seven percent of the population is going to be on the drugs by […]